| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Camptothecin | GDSC1000 | pan-cancer | AAC | -0.032 | 0.4 |
| mRNA | selumetinib:piperlongumine (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.034 | 0.4 |
| mRNA | SB-525334 | CTRPv2 | pan-cancer | AAC | 0.036 | 0.4 |
| mRNA | sitagliptin | CTRPv2 | pan-cancer | AAC | -0.073 | 0.4 |
| mRNA | (5Z)-7-Oxozeaenol | GDSC1000 | pan-cancer | AAC | -0.029 | 0.4 |
| mRNA | quizartinib | CTRPv2 | pan-cancer | AAC | -0.036 | 0.4 |
| mRNA | AM-580 | CTRPv2 | pan-cancer | AAC | -0.036 | 0.4 |
| mRNA | staurosporine | CTRPv2 | pan-cancer | AAC | 0.069 | 0.4 |
| mRNA | Panobinostat | CTRPv2 | pan-cancer | AAC | -0.032 | 0.4 |
| mRNA | CEP-701 | GDSC1000 | pan-cancer | AAC | -0.03 | 0.4 |